6,334
90
IMPower133 clinical trial leads to Tecentriq Approval for initial treatment for SCLC: Imfinzi produces similar outcome
Momelotinib to begin clinical trial in individuals with Myelofibrosis
Lenvima-Keytruda precision cancer medicine combination FDA Approved as new treatment option for advanced uterine cancer.
Tagrissio, Tarceva and other TKI therapy for EGFR + NSCLC continue to evolve and improve survival.
Blincyto, REGN1979, AMG420 BiTE® and 2019 American Society of Clinical Oncology update.
A thyroid cancer survivor shares valuable information about the disease and insight into the treatment process.
Selpercatinib is a precision cancer medicine that targets RET in some NSCLC patients.
Tepotinib is a novel precision cancer medicine capable of targeting NSCLC with MET 14 exon skipping alterations
Pivotal clinical trial fails to confirm benefit of 511 & Toca FC in recurrent High-Grade Glioma.
Good Day everyone, just want to share my experience here so you all should be more careful when…
I am Carlene Rubmo from USA. I am here to say thanks to this herbal doctor from African DR AFRID who…
Do anyone still doubt natural herbs? I've seen the great importance of natural herbs and the…
I thank Dr.Maleek, He helped me with a quick cure for my fibroid of more than 5 years, and its size…
Am Sharif Jenkins from united state, how can i say this to every one out there for more than 20…
Photodynamic therapy for neck cancer - good overview. Anyone have experience? …
Is anyones doctor recommending treatment with a checkpoint inhibitor? These seem like they could be…
I have small cell lung cancer; radiation to prevent spread to the brain has been recommended but…
